ITEMS IN AFP WITH KEYWORD:
Oct 1, 2012 Issue
ACIP Updates Guideline on Influenza Vaccination for 2012-2013 Season [Practice Guidelines]
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) has issued its annual guideline on influenza vaccination. This year’s guideline provides information on dosing considerations for children six months to eight years of age, febrile seizure...
Treating previously healthy patients with oseltamivir (Tamiflu) reduces the duration of influenza symptoms by approximately 21 hours, but it does not reduce the risk of hospitalization in this population.1 The data are insufficient to determine whether oseltamivir reduces the complications or transmission of influenza.
Oct 1, 2011 Issue
ACIP Updates Guideline on Influenza Vaccination for 2011-2012 Season [Practice Guidelines]
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention has issued its annual guideline on vaccination against influenza. It includes information on a newly licensed intradermal vaccine, a change in the number of vaccine doses required in children si...
Influenza is a contagious airborne viral illness characterized by abrupt onset of symptoms. Fever, myalgia, headache, rhinitis, sore throat, and cough are commonly reported symptoms. The diagnosis should be made clinically, and the decision to begin antiviral therapy should not be delayed for labora...
Appropriate and expedited triaging in health care settings will be an important preventive step to minimize exposures and disease spread through the community.
Oct 1, 2010 Issue
CDC Updates Guidelines for Influenza Vaccination for 2010-2011 Season [Practice Guidelines]
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) has released updated recommendations on influenza control for the 2010–2011 season. Seasonal influenza vaccines in 2010–2011 will contain A/California/7/2009 (H1N1)-like, A/Perth/16/2009 (...
Aug 1, 2010 Issue
Neuraminidase Inhibitors for Influenza Treatment and Prevention in Healthy Adults [Cochrane for Clinicians]
Although neuraminidase inhibitors can reduce the risk of contracting symptomatic, confirmed influenza and reduce the time to recovery for those with laboratory-confirmed influenza, they are not effective for reducing the risk of influenza-like illness or asymptomatic influenza infection in healthy a...
The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC) has published specific recommendations for vaccination against the novel influenza A (H1N1) virus, in addition to its recommendations for seasonal influenza vaccination.